Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Joyce

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Synapse (New York, N.Y.)|January 1, 1995
Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonismP A Frohna, D S Rothblat, J N Joyce, et al.
Brain Research|July 16, 1986
Age-related regional loss of caudate-putamen dopamine receptors revealed by quantitative autoradiographyJ N Joyce, S K Loeschen, D W Sapp, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's diseaseJ N Joyce, G Smutzer, C J Whitty, et al.
Neurobiology of Aging|November 28, 2006
Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementiaE R Bychkov, V V Gurevich, J N Joyce, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 6, 1998
Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's diseaseJ N Joyce, A M Murray, H I Hurtig, et al.
Brain Research|September 24, 1986
Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor densityJ N Joyce, J F Marshall, K S Bankiewicz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 1, 1993
Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenicsJ N Joyce, A Shane, N Lexow, et al.
Archives of General Psychiatry|March 1, 1997
Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem studyE V Gurevich, Y Bordelon, R M Shapiro, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 1994
Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic studyJ Ułas, F B Weihmuller, L C Brunner, et al.
Annals of Neurology|March 1, 1995
Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonismA M Murray, F B Weihmueller, J F Marshall, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Synapse (New York, N.Y.)|January 1, 1995
Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonismP A Frohna, D S Rothblat, J N Joyce, et al.
Brain Research|July 16, 1986
Age-related regional loss of caudate-putamen dopamine receptors revealed by quantitative autoradiographyJ N Joyce, S K Loeschen, D W Sapp, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's diseaseJ N Joyce, G Smutzer, C J Whitty, et al.
Neurobiology of Aging|November 28, 2006
Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementiaE R Bychkov, V V Gurevich, J N Joyce, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 6, 1998
Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's diseaseJ N Joyce, A M Murray, H I Hurtig, et al.
Brain Research|September 24, 1986
Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor densityJ N Joyce, J F Marshall, K S Bankiewicz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 1, 1993
Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenicsJ N Joyce, A Shane, N Lexow, et al.
Archives of General Psychiatry|March 1, 1997
Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem studyE V Gurevich, Y Bordelon, R M Shapiro, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 1994
Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic studyJ Ułas, F B Weihmuller, L C Brunner, et al.
Annals of Neurology|March 1, 1995
Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonismA M Murray, F B Weihmueller, J F Marshall, et al.
Pageof 9